文献速递神经肿瘤

低级别胶质瘤生长的影像学报告低估肿瘤实际增大

Radiology reporting of low-grade glioma growth underestimates tumor expansion.
PubMed 文献 · Acta Neurochir (Wien) · 2019-02-13

研究回顾性比较影像学对弥漫性低级别胶质瘤(LGG)生长或稳定的判读与手动分割测量体积变化。影像判读为稳定的肿瘤中位体积增加5.1 mL(11.1%),判读为生长的肿瘤中位体积增加13.3 mL(23.7%)。作者认为当前影像报告流程未能识别和传达LGG的真实增大。

要点

  • 影像判读为稳定的LGG中位体积仍增加5.1 mL(11.1%)。
  • 三维径线测量与分割体积一致性优于一维和二维测量。
  • 体积分析仍是评估LGG生长的金标准,三维径线测量可能为可接受的替代方案。

核心结论

  • 当前影像报告流程未能识别并传达LGG的真实增大。
  • 体积分析仍是评估LGG生长的金标准,仔细的三维径线测量可能为可接受的替代方案。

研究设计与样本

  • 回顾性比较影像学对LGG生长或稳定的判读与手动分割测量的体积变化。
  • 同时测量肿瘤一维、二维和三维直径以评估RECIST标准、Macdonald/RANO标准及平均肿瘤直径/椭球体法等进展评估方法。

主要发现

  • 影像判读为稳定的肿瘤中位体积增加5.1 mL(11.1%),判读为生长的肿瘤中位体积增加13.3 mL(23.7%)。
  • 基于直径的测量与分割体积对应良好但倾向于高估金标准分割体积。
  • 与分割体积测量的一致性在一维、二维、三维影像测量时直径分别为17.6 ± 8.0 mm、4.5 ± 5.8 mm、3.9 ± 3.6 mm,体积分别为104.0 ± 96.6 mL、25.3 ± 36.8 mL、15.9 ± 21.3 mL。
  • 测量高估随肿瘤增大而增加。

临床怎么用

  • 作者认为,鉴于LGG体积和生长为预后因素的证据不断增加,需要客观的病灶测量。
  • 作者认为体积分析仍是评估生长的金标准,仔细的三维径线测量可能为可接受的替代方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: An important aspect in the management of patients with diffuse low-grade gliomas (LGGs) involves monitoring the lesions via serial magnetic resonance imaging (MRI). However, radiological interpretations of LGG interval scans are often qualitative and thus difficult to use clinically. METHODS: To contextualize these assessments, we retrospectively compared radiological interpretations of LGG growth or stability to volume change measured by manual segmentation. Tumor diameter was also measured in one, two, and three dimensions to evaluate reported methods for assessment of glioma progression, including RECIST criteria, Macdonald/RANO criteria, and mean tumor diameter/ellipsoid method. RESULTS: Tumors evaluated as stable by radiologists grew a median volume of 5.1 mL (11.1%) relative to the comparison scan, and those evaluated as having grown had a median volume increase of 13.3 mL (23.7%). Diameter-based measurements corresponded well but tended to overestimate gold standard segmented volumes. In addition, agreement with segmented volume measurements improved from 17.6 ± 8.0 to 4.5 ± 5.8 to 3.9 ± 3.6 mm for diameter and from 104.0 ± 96.6 to 25.3 ± 36.8 to 15.9 ± 21.3 mL for volume with radiological measurements in one, two, and three dimensions, respectively. Measurement overestimation increased with tumor size. CONCLUSIONS: Given accumulating evidence that LGG volume and growth are prognostic factors, there is a need for objective lesion measurement. Current radiological reporting workflows fail to appreciate and communicate the true expansion of LGGs. While volumetric analysis remains the gold standard for assessment of growth, careful diametric measurements in three dimensions may be an acceptable alternative.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Gui C, Lau JC, Kosteniuk SE, et al. Radiology reporting of low-grade glioma growth underestimates tumor expansion. Acta Neurochir (Wien). 2019. PMID: 30756242. doi:10.1007/s00701-018-03783-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。